Director, Epidemiology and Real-World evidence (EpiRWE)-Oncology

Gilead Sciences•Parsippany, NJ
•$205,615 - $292,710•Onsite

About The Position

Gilead is seeking a Director, Epidemiology and Real-World Evidence (EpiRWE) – Oncology to design and deliver real-world evidence (RWE) for internal stakeholders and regulators, ensuring its timeliness, quality, and utility. The Director advises on methodological approaches, including support for payer and provider interactions. The role calls for a strong record in epidemiologic study design and execution, direct experience applying RWE at different stages of product development and commercialization, and the ability to manage work and resources in a cross-functional, matrix environment. This office-based position is located in either Foster City, California, or Parsippany, New Jersey. The Director is accountable for developing, executing, and communicating global RWE strategy for one or more Oncology products, supporting late-stage clinical development and post-authorization evidence requirements. The role works with quantitative and clinical functions and other partners to meet evidence needs for regulators, payers, providers, and patients. The position also contributes to observational research communications and regulatory documents, represents RWE in cross-functional teams, and helps improve functional processes and training. As a people leader, the Director is responsible for fostering inclusion, developing talent, and empowering teams.

Requirements

  • A doctoral degree (e.g., PhD, MD, ScD, PharmD) and/or a master's degree (e.g., MSc, MPH) in Epidemiology or a related discipline, such as Outcomes Research, Medicine, or Biostatistics, from an accredited institution.
  • At least 8 years of relevant experience with a PhD or 10 years with a master's degree; the posting prefers at least 6 years of experience in the biopharmaceutical industry.
  • Direct experience applying RWE in different contexts, including early- and/or late-stage clinical development, regulatory approvals, and/or safety commitments.
  • Experience designing and conducting observational research, including developing protocols, statistical analysis plans, and study reports.
  • Experience with secondary data analysis, including electronic medical record and/or medical claims databases, and statistical analysis tools such as SAS and R.
  • Experience leading studies and projects in a matrix environment.
  • Ability to work autonomously and develop productive cross-functional collaborations.
  • Ability to manage priorities, resources, and performance targets.
  • Well-developed cross-cultural sensitivity.

Nice To Haves

  • A track record of scientific publications demonstrating expertise in observational study design, analysis, and interpretation.
  • Knowledge of the Oncology therapeutic area.

Responsibilities

  • Serve as the single point of accountability for developing, executing, and communicating global RWE strategy for one or more Oncology products, supporting late-stage clinical development and post-authorization evidence requirements.
  • Use robust scientific methods and fit-for-purpose data to execute RWE strategy on time and in alignment with clinical development plans and broader CST/EMT objectives.
  • Generate real-world evidence within time, budget, and quality standards, including evidence on disease natural history, population characteristics, treatment patterns and unmet need, external comparators, clinical outcome benchmarks, comparative safety and effectiveness, and post-authorization studies.
  • Ensure observational study conduct requirements are fulfilled, including registration, ethical board approval, protocols, statistical analysis plans, study reports, and disclosure.
  • Communicate the utility of RWE across the product lifecycle and promote the use of study and analysis results in internal and external decisions.
  • Contribute to communication of observational research results, including relevant regulatory document sections, publications, and white papers.
  • Contribute to development of epidemiological sections of worldwide regulatory documents, including risk management plans, orphan or breakthrough designations, Pediatric Investigation Plans, query responses, and advisory committee briefing documents.
  • Represent the RWE function in internal cross-functional teams and initiatives.
  • Collaborate with quantitative functions within CDS, including Biostatistics and Bioinformatics, and with Clinical Research, Patient Safety, Medical Affairs, and Global Value and Access to address evidence needs of regulators, payers, providers, and patients.
  • Identify needs for and contribute directly to processes and training that improve the efficiency, quality, and impact of functional activities.
  • As a people leader, model inclusion, develop and coach employees, align team goals with organizational objectives, hold the team accountable, and help remove barriers.

Benefits

  • Discretionary annual bonus eligibility.
  • Discretionary stock-based long-term incentives; eligibility may vary by role.
  • Paid time off.
  • Company-sponsored medical, dental, vision, and life insurance plans.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service